LNB
ACOR

Ledyard National Bank’s Acorda Therapeutics ACOR Stock Holding History

Ledyard National Bank’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Hold
0
– -$1K – 737
2015
Q1 		– Hold
0
– – – 696
2014
Q4 		– Hold
0
– – – 717
2014
Q3 		– Sell
-1
Closed -$3.75K – 699
2014
Q2 		$2K Hold
1
– – ﹤0.01% 691
2014
Q1 		$2K Hold
1
– – ﹤0.01% 683
2013
Q4 		$2K Buy
+1
New +$3.9K ﹤0.01% 694

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ledyard National Bank's ACOR Position: Q2 2015 in Review

Ledyard National Bank held its Acorda Therapeutics (ACOR) position steady in Q2 2015 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #737.

Ledyard National Bank first reported a position in ACOR in Q4 2013 and has held it in 3 quarters since. The position peaked at $2K in Q2 2014. 170 funds tracked by Wall St. Rank hold ACOR as of Q2 2015.

  • Ledyard National Bank held 0 shares of Acorda Therapeutics worth $0 as of Q2 2015.
  • Ledyard National Bank left its Acorda Therapeutics share count unchanged in Q2 2015.
  • Acorda Therapeutics made up ﹤0.01% of Ledyard National Bank's portfolio in Q2 2015, its #737 holding.
  • Ledyard National Bank first reported a position in Acorda Therapeutics in Q4 2013 and has held it in 3 quarters since.
  • Ledyard National Bank's Acorda Therapeutics position peaked at $2K in Q2 2014.
  • 170 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2015.

Based on Ledyard National Bank's 13F filing for Q2 2015, filed 16 Jul 2015.